Search results for Claudin 18.2 Antibody

Claudin 18.2 Antibody, MedChemexpress, HY-P81773

Claudin 18.2 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to Claudin 18.2.

Claudin 18.2 antibody [GT206], Genetex, GTX643617

Claudin 18.2 antibody [HL5024], Genetex, GTX645117

Claudin 18.2 antibody [HL5230], Genetex, GTX645486

Claudin 18.2 antibody [ARC5062-02], Genetex, GTX04575

Anti-Claudin 18.2 antibody [EPR19202], Abcam, AB222512

Anti-Claudin 18.2 antibody [EPR19202] (ab222512) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-Fr and IHC-P Abcam's high quality manufacturing and validation processes ensure Anti-Claudin 18.2 antibody [EPR19202] (ab222512) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Claudin 18.2 antibody [EPR19202] (ab222512) specifically detects Claudin 18.2 (UniProt ID: P56856; Molecular weight: 28kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR19202 - ab240400 . Antibody clone EPR19202 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647, Alexa Fluor ® 594, Alexa Fluor ® 568, Alexa Fluor ® 555, Alexa Fluor ® 750 ( ab311014 , ab311142 , ab311779 , ab313060 , ab313260 , ab321409 ). Claudin 18.2 (CLDN18.2) is a highly selective protein found in the tight junctions of gastric epithelial cells. It becomes accessible on the surface of tumor cells during malignant transformation, making it a valuable target for cancer therapy. CLDN18.2 is predominantly expressed in gastric and gastroesophageal cancers but is also found in other solid tumors. Researchers are developing targeted therapies, including monoclonal antibodies, bispecific antibodies and CAR-T cells, to exploit CLDN18.2's unique expression pattern. These therapies show promise in improving treatment outcomes for patients with CLDN18.2-positive cancers. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

Anti-Claudin 18.2 antibody [EPR19202-244], Abcam, AB241330

What is this antibody validated in? Anti-Claudin 18.2 antibody [EPR19202-244] (ab241330) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Human, Mouse, Rat samples. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [EPR19202-244] also available for your convenience: ab241330, Carrier free - ab242079 , Alexa Fluor® 594 - ab311780 , Alexa Fluor® 568 - ab313061 , Alexa Fluor® 555 - ab313261 , Alexa Fluor® 750 - ab321490 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Claudin 18.2 antibody [EPR19202] - BSA and Azide free, Abcam, AB240400

What is this antibody validated in? Anti-Claudin 18.2 antibody [EPR19202] (ab240400) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Human, Mouse, Rat samples. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.

Alexa Fluor® 488 Anti-Claudin 18.2 antibody [EPR19202], Abcam, AB311014

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Alexa Fluor® 555 Anti-Claudin 18.2 antibody [EPR19202], Abcam, AB313260

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.